FIXX - Homology Medicines, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 5/28/2020
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) -0.16
52-Week Change 3-27.45%
S&P500 52-Week Change 38.87%
52 Week High 324.00
52 Week Low 311.05
50-Day Moving Average 314.09
200-Day Moving Average 316.42

Share Statistics

Avg Vol (3 month) 3411.13k
Avg Vol (10 day) 3565.97k
Shares Outstanding 545.21M
Float 23.36M
% Held by Insiders 15.41%
% Held by Institutions 188.86%
Shares Short (May 14, 2020) 42.9M
Short Ratio (May 14, 2020) 45.67
Short % of Float (May 14, 2020) 48.63%
Short % of Shares Outstanding (May 14, 2020) 46.42%
Shares Short (prior month Apr 14, 2020) 43.18M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-6,114.52%

Management Effectiveness

Return on Assets (ttm)-29.06%
Return on Equity (ttm)-57.58%

Income Statement

Revenue (ttm)1.98M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)117.80%
Gross Profit (ttm)-87.73M
EBITDA -114.35M
Net Income Avi to Common (ttm)-115.39M
Diluted EPS (ttm)-2.62
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)234.93M
Total Cash Per Share (mrq)5.2
Total Debt (mrq)17.15M
Total Debt/Equity (mrq)7.57
Current Ratio (mrq)13.66
Book Value Per Share (mrq)5.01

Cash Flow Statement

Operating Cash Flow (ttm)-99.33M
Levered Free Cash Flow (ttm)-76.16M